Literature DB >> 7542796

Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy.

R F Spaide1, L A Yannuzzi, J S Slakter, J Sorenson, D A Orlach.   

Abstract

PURPOSE: To identify the precise choroidal abnormalities associated with idiopathic polypoidal choroidal vasculopathy (IPCV), patients with IPCV were examined with indocyanine green (ICG) videoangiography.
METHODS: Twelve patients with IPCV were examined using standard clinical, fluorescein, and ICG videoangiographic techniques.
RESULTS: Indocyanine green videoangiography showed two basic choroidal vascular changes: a branching network of vessels in the inner choroid, and vascular dilations at the border of the network of vessels. The vascular dilations appeared to be associated with the exudative and hemorrhagic manifestations of IPCV.
CONCLUSION: The choroidal vasculopathy seen in IPCV is distinct from the changes seen in other choroidal abnormalities. Recognition of these changes aids in diagnosis and patient management, since the clinical implications of IPCV differ from those of other similar entities.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542796     DOI: 10.1097/00006982-199515020-00003

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  154 in total

1.  Polymorphisms in the VEGF-A in polypoidal choroidal vasculopathy in a Korean population.

Authors:  Dong Ho Park; In Taek Kim
Journal:  Jpn J Ophthalmol       Date:  2012-02-04       Impact factor: 2.447

2.  Baseline polyp size as a potential predictive factor for recurrence of polypoidal choroidal vasculopathy.

Authors:  Hae Min Kang; Hyoung Jun Koh; Sung Chul Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-21       Impact factor: 3.117

3.  Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection.

Authors:  Masaaki Saito; Mariko Kano; Kanako Itagaki; Shigeyuki Ise; Kimihiro Imaizumi; Tetsuju Sekiryu
Journal:  Jpn J Ophthalmol       Date:  2015-09-09       Impact factor: 2.447

4.  The origins of polypoidal choroidal vasculopathy.

Authors:  M Yuzawa; R Mori; A Kawamura
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

5.  Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin.

Authors:  Kaori Sayanagi; Fumi Gomi; Miki Sawa; Masahito Ohji; Yasuo Tano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-17       Impact factor: 3.117

6.  Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography.

Authors:  Fumi Gomi; Miki Sawa; Keiichi Mitarai; Motokazu Tsujikawa; Yasuo Tano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-09       Impact factor: 3.117

7.  Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study.

Authors:  A Okubo; M Sameshima; A Uemura; S Kanda; N Ohba
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

8.  Combined therapy versus anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy: a Meta-analysis.

Authors:  Long-Hui Han; Li-Fei Yuan; Xu Liang; Xin Jia; Ming-Lian Zhang
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

9.  Polypoidal choroidal vasculopathy in patients aged less than 50 years: characteristics and 6-month treatment outcome.

Authors:  Young Suk Chang; Jae Hui Kim; Jong Woo Kim; Tae Gon Lee; Chul Gu Kim; Sung Won Cho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-19       Impact factor: 3.117

10.  Polypoidal choroidal vasculopathy in elderly Chinese patients.

Authors:  Feng Wen; Changzheng Chen; Dezheng Wu; Haitao Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-29       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.